EUVIMEDEUVIMED entdecken
Open Access

On-the-spot spirometry & combined salbutamol & glycopyrronium reversibility testing in obstructive airway disease: A real-world appraisal

Parthasarathi Bhattacharyya, Srijita Sen, Shuvam Ghosh, Debkanya Dey, Sayoni Sengupta, Sayanti Karmakar, Dipanjan Saha, Avishek Kar, Rajat Banerjee

The Indian Journal of Medical Research · 2024

DOI: 10.25259/ijmr_2404_23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Indian Journal of Medical Research, 2024. Verfasst von Parthasarathi Bhattacharyya und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Institute of Pulmocare & Research, Kolkata, West Bengal, India. Hauptthemen laut MEDLINE: Spirometry, Glycopyrrolate, Albuterol, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background & objectives Spirometric glycopyrronium responsiveness, a new advent, needs to be examined at in terms of degree and frequency in different obstructive-airway diseases diagnosed in real world practise. Methods Serial and willing symptomatic affected individuals of suspected airway disease underwent a pragmatic post-consultation spirometry-protocol on the same day with salbutamol followed by glycopyrronium bromide. The diagnosis of asthma (FEV 1 -reversibility ≥ 200 ml + 12%), chronic obstructive pulmonary disease (COPD) (FEV 1 /FVC

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SpirometryGlycopyrrolateAlbuterolPulmonary Disease, Chronic ObstructiveAsthmaHumansMaleFemaleMiddle AgedAdultAgedBronchodilator AgentsForced Expiratory Volume

Stichwörter der Autor:innen

Bronchodilator-responsivenessglycopyrronium-responsivenessobstructive airway diseasesalbutamolspirometry

Substanzen

GlycopyrrolateAlbuterolBronchodilator Agents

Autor:innen und Institutionen

  • Department of Pulmonary Medicine, Institute of Pulmocare & Research, Kolkata, West Bengal, India.
  • Department of Airway Diseases, Institute of Pulmocare & Research, Kolkata, West Bengal, India.
  • Department of Biotechnology, and Dr BC Guha Centre for Genetic Engineering and Biotechnology, University of Calcutta, Kolkata, West Bengal, India.
  • Department of Pleuro-parenchymal Diseases, Institute of Pulmocare & Research, Kolkata, West Bengal, India.
  • Department of Microbiology, Sister Nivedita University, Kolkata, West Bengal, India.

Zitieren

APA

Bhattacharyya, P., Sen, S., Ghosh, S., Dey, D., Sengupta, S., Karmakar, S., Saha, D., Kar, A., & Banerjee, R. (2024). On-the-spot spirometry & combined salbutamol & glycopyrronium reversibility testing in obstructive airway disease: A real-world appraisal. The Indian Journal of Medical Research. https://doi.org/10.25259/ijmr_2404_23

Vancouver

Bhattacharyya P, Sen S, Ghosh S, Dey D, Sengupta S, Karmakar S, et al. On-the-spot spirometry & combined salbutamol & glycopyrronium reversibility testing in obstructive airway disease: A real-world appraisal. The Indian Journal of Medical Research. 2024. doi:10.25259/ijmr_2404_23

BibTeX
@article{Bhattacharyya2024,
  author = {Bhattacharyya, Parthasarathi and Sen, Srijita and Ghosh, Shuvam and Dey, Debkanya and Sengupta, Sayoni and Karmakar, Sayanti and Saha, Dipanjan and Kar, Avishek and Banerjee, Rajat},
  title = {On-the-spot spirometry & combined salbutamol & glycopyrronium reversibility testing in obstructive airway disease: A real-world appraisal},
  journal = {The Indian Journal of Medical Research},
  year = {2024},
  doi = {10.25259/ijmr_2404_23}
}
Kostenlos starten →